The ARCHITECT i1000SR immunoassay analyzer meets your laboratory's high standards REFER TO THE Operations Manual or User Guide FOR WARNINGS, Weight. With lower labor costs and less human error than the manual version, the Abbott automatic dilution Architect assay provided a good clinical performance with regard to the HBsAg levels.ABBOTT ARCHITECT I1000SR SPECIFICATIONS MANUAL FOR NATIONAL HOSPITAL INPATIENT > DOWNLOADĪBBOTT ARCHITECT I1000SR SPECIFICATIONS MANUAL FOR NATIONAL HOSPITAL INPATIENT > READ ONLINEĪbbott architect ci4100 manual pdf abbott architect i1000sr user manual pdf abbott architect i2000sr manual pdf abbott architect c8000 user manual pdfabbott architect reagents abbott architect i1000sr principle abbott architect c4000 user manual abbott architect c4000 manual pdf In conclusion, the correlation between the automatic and manual dilution Architect assays was feasible, particularly in the HBeAg-negative and low DNA groups. Results of the two Architect assays demonstrated a feasible correlation ( n = 130 samples R = 0.898, p 0.93 in all cases). The coefficients of variation (0.44–9.53%) and R 2 = 0.996–1, which were both determined using values obtained from the automatic Architect assay, showed good reproducibility and linearity. Among the 87 patients, 41 provided 42 sera samples to confirm the linearity and reproducibility of the automatic Architect assay, and find out the correlation among the Elecsys and two Architect assays. A total of 130 sera samples obtained from 87 hepatitis B virus (HBV)-infected patients were collected to assess the correlation between the automatic and manual Architect assays. We aimed to evaluate the performance of the Abbott HBsAg quantification assay with automatic sample dilutions (shortened as automatic Architect assay), compared with the Abbott HBsAg quantification assay with manual sample dilutions (shortened as manual Architect assay) and the Roche HBsAg quantification assay with automatic sample dilutions (shortened as Elecsys). The Abbott HBsAg quantification assay provides enhanced detection of HBsAg and HBsAg mutants. Hepatitis B virus surface antigen (HBsAg) levels reflect disease status and can predict the clinical response to antiviral treatment however, the emergence of HBsAg mutant strains has become a challenge.

Abbott architect i1000 manual